Effects of hematopoietic growth factors on interleukin 6 secretion by blast cells derived from acute myelogenous leukemia patients

Acta Haematologica

Volumn 96, Issue 3, 1996, Pages 155-161

  Bruserud, O ^a   Pawelec, G ^b   Buhring H J ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Acute myelogenous leukemia; Interleukin 1; Interleukin 4; Interleukin 6; Macrophage colony stimulating factor; Stem cell factor

Indexed keywords

COLONY STIMULATING FACTOR 1; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN SECRETION;

ADULT; AGED; CYTOKINES; FEMALE; GROWTH SUBSTANCES; HEMATOPOIESIS; HUMANS; INTERLEUKIN-4; INTERLEUKIN-6; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; TUMOR CELLS, CULTURED;

EID: 0029781493     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203754     Document Type: Article

References (26)

1. Hirano T: The biology of interleukin 6. Chem Immunol 1992;51:153-180.
2. Takanashi M, Motoji T, Masuda M, Oshimi K, Mizoguchi H: The effect of leukemia inhibitory factor and interleukin 6 on the growth of acute myelogenous leukemia cells. Leuk Res 1993; 17:217-222.
3. Pawelec G: Immune surveillance in leukemia: Rationale for immunotherapy. Hematol Rev 1994;8:123-147.
4. Brach M, Stone R, Kufe D: CSFs in combination with cytosine arabinoside, an inhibitor of DNA synthesis; potential strategies for the treatment of myeloid disorders. Biotcchnol Ther 1991;2:269-283.
5. Bennett JM, Catowsky D, Daniel MT, Flan-drin G, Galton DAG, Gralnick HR, Sultan C: Proposals for the classification of the acute leu-kemias. Br J Hematol 1976;33:451-458.
6. Carow CE, Hangoc G, Cooper SH, Williams DE. Broxmeyer HE: Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential. Blood 1991;78:2216-2221.
7. Asano Y, Okamura S, Shibuya T, Harada M, Niho Y: Growth of clonogenic myeloblastic leukemia cells in the presence of human recombinant erythropoietin in addition to various human recombinant hematopoietic growth factors. Blood 1988;72:1682-1686.
8. Nara N, McCulloch EA: The proliferation in suspension of the progenitors of the blast cells in acute myeloblastic leukemia. Blood 1985;65: 1484-1493.
9. Vellcnga E, deWolf JTM, Beentjes JAM, Esse-link MT, Smit JW, Halie MR: Divergent effects of interleukin 4 on the granulocyte colony-stimulating factor and IL3-supported myeloid colony formation from normal and leukemic bone marrow cells. Blood 1990;75:633-637.
10. Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD: Proliferative response of acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL3, GM-CSF and G-CSF. Leukemia 1991;5:386-391.
11. Kerangeuven F. Sempere C, Tabilio A, Man-noni P: Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells. Eur Cytokine Net 1990;1:99-107.
12. Bruserud O: Effect of dipyridamole, theophyl-lamine and verapamil on spontaneous in vitro proliferation of myelogenous leukaemia cells. Acta Oncol 1992;31:53-58.
13. Rambaldi A, Torcia M, Bettoni S, Vannier E, Barbui T, Shaw AR, Dinarello CA, Cozzolino F: Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin 1 receptor antagonist and lack of its expression by leukemic cells. Blood 1991;78:3248-3253.
14. Bruserud O, Nesthus I, Biihring H-J, Pawelec G: Cytokine modulation of interleukin 1 and tumor necrosis factor a secretion from acute myelogenous leukemia blast cells in vitro. Leuk Res 1995;19:15-22.
15. Elbaz O, Budel LM, Hoogcrbrugge H, Touw IP, Delwel R, Mahmoud LA. Lowenberg B: Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin 3 receptors on human acute myeloid leukemia cells. Blood 1991:77: 989-995.
16. Sissolak G, Hoffbrand AV, Mehta AB, Ganc-shaguru K: Effects of interferon β, interleukin 6. granulocyte-macrophage colony-stimulating factor and tumor necrosis factor a in acute myeloid leukemia blasts. Leukemia 1992;6: 1155-1160.
17. McGlave PB, Haake RJ, Bostrom BC, Brun-ning R. Hurd DD, Kim TH, Nesbit ME, Vcr-cellotti GM, Weisdorf D, Woods WG, Ramsay NKC, Kersey JH: Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission. Blood 1988;72:1512-1517.
18. Dcmetri GD, Griffin JD: Granulocyte colony-stimu.ating factor and its receptor. Blood 1991; 78:2791-2808.
19. Russel NH: Autocrine growth factors and leukemic hacmatopoiesis. Blood Rev 1992;6:149-156.
20. Bruserud O, Gjertsen BT, Brustugun OT, Bassoc CF, Nesthus I, Akselsen P-E, Biihring H-J, Pawelec G: Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia. Leukemia 1995;9:1910-1920.
21. Zhu Y-M, Bradbury DA, Russel NH: Wild type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukemic cells. Br J Cancer 1994;69:468-472.
22. McNiece IK, Langley KE, Zsebo KM: Recombinant human stem cell factor synergies with GM-CSF, G-CSF, IL3 and Epo to stimulate human progenitor cells of the myeloid and ery-throid lineages. Exp Hematol 1991; 19:226-231.
23. Jansen JH, Fibbe WE, Wicntjens GJ, Willemze R. Kluin-Nelemans JC: Inhibitory effect of Interleukin 4 on the proliferation of acute myeloid leukemia cells with myelo-monocytic differentiation (AML-M4/M5); the role of interleukin 6. Leukemia 1993;7:643-645.
24. Bataille R, Zhang XG, Wijdenes J, Schved JF, Klein B: Effects of an anti-interleukin 6 (IL6) murine monoclonal antibody in a patient with acute monoblastic leukemia. Med Oncol Tumor Pharmacothcr 1993;10:185-188.
25. Lotem J, Sachs L: Regulation of leukemic cells by interleukin 6 and leukemia inhibitory factor. Ciba Found Symp 1992;167:80-99.
26. Bullock G, Tang C, Tourkina E, Ibrado AM, Lutzky J, Huang Y, Mahoney ME, Bhalla K: Effects of combined treatment with interleukin 3 and interleukin 6 on 4-hydropcroxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells. Exp Hematol 1993;21:1640-1647.